Menu

Filter articles published since 2015 by topic, disease, or article type.

Guidlines for filtering

Results are filtered to show all matching articles from a particular category, and to show only articles that match all selected categories.

For instance, if "Biomarkers" and "Genetics" are selected in the Topic category, and "Multiple sclerosis" is selected in the Disease category, all results that match EITHER the Biomarkers OR Genetics Topic category will be shown, but only if they also match the Multiple sclerosis Disease category; i.e. Boolean search of [("Biomarkers" OR "Genetics") AND "multiple sclerosis"]

Filter articles published since 2015 by topic, disease, or article type.

Guidlines for filtering

Results are filtered to show all matching articles from a particular category, and to show only articles that match all selected categories.

For instance, if "Biomarkers" and "Genetics" are selected in the Topic category, and "Multiple sclerosis" is selected in the Disease category, all results that match EITHER the Biomarkers OR Genetics Topic category will be shown, but only if they also match the Multiple sclerosis Disease category; i.e. Boolean search of [("Biomarkers" OR "Genetics") AND "multiple sclerosis"]

Biogen Idec Partners with University of Edinburg on MS and MND Research

Biogen Idec just announced that they will be collaborating with the University of Edinburgh in Scotland to further understand multiple sclerosis (MS) and motor neuron disease (MND). The three year collaboration will focus on using the strengths of each partner to identify potential therapeutics for MS and MND. Biogen’s VP of neurology research, Ken Rhodes, said the partnership will “provide an in-depth portrait of the pathophysiology of multiple sclerosis and motor neuron disease, while identifying important new targets for potential therapies.” Biogen is committed to continuing to invest in ALS, in fact, they just announced an ALS-focused “Manhattan Project.” Stay tuned to the ALS Forum for additional updates about this new project!

Biogen Idec just announced that they will be collaborating with the University of Edinburgh in Scotland to further understand multiple sclerosis (MS) and motor neuron disease (MND). The three year collaboration will focus on using the strengths of each partner to identify potential therapeutics for MS and MND. Biogen’s VP of neurology research, Ken Rhodes, said the partnership will “provide an in-depth portrait of the pathophysiology of multiple sclerosis and motor neuron disease, while identifying important new targets for potential therapies.” Biogen is committed to continuing to invest in ALS, in fact, they just announced an ALS-focused “Manhattan Project.” Stay tuned to the ALS Forum for additional updates about this new project!

Filter articles published since 2015 by topic, disease, or article type.

Guidlines for filtering

Results are filtered to show all matching articles from a particular category, and to show only articles that match all selected categories.

For instance, if "Biomarkers" and "Genetics" are selected in the Topic category, and "Multiple sclerosis" is selected in the Disease category, all results that match EITHER the Biomarkers OR Genetics Topic category will be shown, but only if they also match the Multiple sclerosis Disease category; i.e. Boolean search of [("Biomarkers" OR "Genetics") AND "multiple sclerosis"]